BILLS-116hr5668ih.pdf
House Resolutions
0 pages
Page
of 0
Loading OCR text...
No OCR text available for this page.
Failed to load OCR text.
DATE (6)
2020
5668
30 days
every 4 years
later than 4 years
JANUARY 24, 2020
EVENT (2)
the ‘‘Making Objective Drug
SESSION
H. R. 5668
FAC (9)
PO 00000
Frm 00008
Fmt
PO 00000
Frm 00002
PO 00000
Frm 00006
PO 00000
Frm 00007
PO 00000
Frm 00009
PO 00000
Frm 00003
Fmt
PO 00000
Frm 00001
PO 00000
Frm 00004
PO 00000
Frm 00005
GPE (1)
the United States of America
LOC (1)
IH
NORP (2)
GE-
Cosmetic
ORG (14)
DSK79L0C42PROD
the Committee on Energy and Commerce
the Federal Food, Drug
Senate
Congress
NERIC
HOLDER
Labor
House of Representa-
the Making Objective Drug Evidence
the House of Representatives
SEC
PERSON (3)
kjohnson
MATSUI
GUTHRIE
Topic Classifications
congressional legislation
97.2%
government oversight
39.5%
public health
30.1%
Extracted Keywords
labeling
covered drug
generic
covered drugs
drug
drugs
clinical practice
version
scientific
evidence
selected
accepted
supplemental
modernize
approved
Forensic Analysis
PDF Metadata
- Creator
- ACOMP.exe WinVer 2.2a Sep 11 2014
- ModDate
- D:20221231220817-05'00'
- Producer
- Acrobat Distiller 19.0 (Windows); modified using iText® Core 7.2.3 (production version) ©2000-2022 iText Group NV, Government Publishing Office
- CreationDate
- D:20200125025520-05'00'
Sentiment
Polarity
Positive
0.101
Subjectivity
36%
Objective